Abstract
The relationship between orthostatic hypotension and chronic fatigue syndrome (CFS) has been reported previously. To study the parthogenesis and management of delayed orthostatic hypotension in patients with CFS, a case comparison study with follow-up of 8 weeks has been designed. A group of 78 patients with CFS (mean age 40 years; 49% men and 51% women), who fulfilled the Centre for Disease Control and Prevention criteria were studied. There were 38 healthy controls (mean age 43 years; 47% men and 53% women). At entry to the study each subject underwent an upright tilt-table test, and clinical and laboratory evaluation. Patients with orthostatic hypotension were offered therapy with sodium chloride (1200 mg) in a sustainedrelease formulation for 8 weeks, prior to resubmission to the tilt-table testing, and clinical and laboratory evaluation. An abnormal response to upright tilt was observed in 22 of 78 patients with CFS. After sodium chloride therapy for 8 weeks, tilt-table testing was repeated on the 22 patients with an abnormal response at baseline. Of these 22 patients, 10 redeveloped orthostatic hypotension, while 11 did not show an abnormal response to the test and reported an improvement of CFS symptoms. However, those CFS patients who again developed an abnormal response to tilt-test had a significantly reduced plasma renin activity (0.79 pmol/ml per h) compared both with healthy controls (1.29 pmol/ml per h) and with those 11 chronic fatigue patients (1.0 pmol/ml per h) who improved after sodium chloride therapy (p=0.04). In conclusion, in our study CFS patients who did not respond to sodium chloride therapy were found to have low plasma renin activity. In these patients an abnormal renin-angiotensin-aldosterone system could explain the pathogenesis of orthostatic hypotension and the abnormal response to treatment.
Similar content being viewed by others
References
McKenzie R, Straus ES. Chronic fatigue syndrome.Adv Int Med 1995;40: 119–153.
Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group.Ann Intern Med 1994;121: 953–959.
Holmes GP, Kaplan JE, Gantz NMet al. Chronic fatigue syndrome: a working case definition.Ann Intern Med 1988;108: 387–389.
bou-Holaigah I, Rowe CP, Kan J, Calkins H. The relationship between neurally mediated hypotension and the chronic fatigue syndrome.JAMA 1995;274: 961–967.
DeLorenzo F, Hargreaves J, Kakkar VV. Possible relationship between chronic fatigue syndrome and postural tachycardia syndromes.Clin Auton Res 1996;6: 263–264.
Rowe CP, bou-Holaigah I, Kan JS, Calkins J. Is neurally mediated hypotension an unrecognised cause of chronic fatigue?Lancet 1995;345: 623–624.
Kaufman H. Neurally mediated syncope: pathogenesis, diagnosis, and treatment.Neurology 1995;45(suppl. 5): 512–518.
Low AP, Opfer-Gehrking TL, Texfor CSet al. Postural tachycardia syndrome (POTS).Neurology 1995;45: S19-S25.
Fouad FM, Tadena Thome L, Bravo ELet al. Idiopathic hypovolemia.Ann Intern Med 1986;104: 298–303.
Rosen SG, Cryer PE. Postural tachycardia syndrome: reversal of sympathetic hyperresponsiveness and clinical improvement during sodium loading.Am J Med 1982;72: 847–850.
Schondorf R, Low PA: Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia?Neurology 1993;43: 132–137.
Polinsky RJ, Kopin IJ, Ebert MHet al. Pharmacologic distinction of different orthostatic hypotension syndromes.Neurology 1981;31: 1–7.
Grubb BP, Temsey-Armos P, Hahn Het al. Utility of upright tilt table testing in the evaluation and management of syncope of unknown origin.Am J Med 1991;90: 6–10.
Strasberg B, Rechavia E, Sagie Aet al. The head up tilt table test in patients with syncope of unknown origin.Am Heart J 1989;118: 923–927.
Almquist A, Goldenberger IF, Nilstein Set al. Provocation of bradycardia and hypotension by isoprotenerol and upright posture in patients with unexplained syncope.N Engl J Med 1989;320: 346–351.
Sra JS, Anderson SJ, Sheik SHet al. Unexplained syncope evaluated by electrophysiologic studies and head up tilt testing.Ann Int Med 1991;114: 1013–1019.
Sheldon R, Killam S. Methodology of isoprotenerol tilt table testing in patients with syncope.J Am Coll Cardiol 1992;19: 773–779.
Waxman MB, Yao L, Cameron DAet al. Isoprotenerol induction of vasodepressor type reaction in vasodepressor persons.Am J Cardiol 1989;63: 58–65.
Chen XC, Chen MY, Remole Set al. Reproducibility of head up tilt table testing for eliciting susceptibility to neurally mediated syncope in patients without structural heart disease.Am J Cardiol 1992;69: 755–760.
Grubb BP, Wolfe D, Temesy Armos Pet al. Reproducibility of head up-right tilt table results in patients with syncope.Pacing Clin Electrophysiol 1992;15: 1477–1481.
Fisk JD, Ritvo PG, Ross L, Haase DA, Marie TJ, Schlech WF, Measuring the functional impact of fatigue: initial validation of the fatigue impact scale.Clinical Infectious Disease 1994;18(suppl. 1): S79–83.
Savage DD, Corwin L, McGee DLet al. Epidemiological features of isolated syncope: The Framingham Study.Stroke 1985;16: 626–629.
Day SC, Cook EF, Funkenstein GHet al. Evaluation and outcome of emergency room patients with transient loss of consciousness.Am J Med 1982;73: 15–23.
Oribe E, Kaufamnn H, Winters Set al. Fludrocortisone versus betaadrenergic blockers in the treatment of vasovagal syncope [abstract].Neurology 1992;42(3): 213.
Thames MD. Effect of d- and l-propranolol on the discharge of cardiac vagal C fibres.Am J Physiol 1980;238: H465–470.
Strieper MJ, Campbell R. Efficacy of alpha-adrenergic agonist therapy for the prevention of pediatric neurocardiogenic syncope.J Am Coll Cardiol 1993;22: 594–597.
McLaren CJ, Gersh BJ, Osborn MJet al. Increased vagal tone as an isolated finding in patients undergoing electrophysiological testing for recurrent syncope: response to long term anticholinergic agents.Br Heart J 1986;55: 53–57.
De Lorenzo F, Kakkar VV. Twenty-four hour urine analysis in patients with orthostatic hypotension and chronic fatigue syndrome (CFS).Aust NZ J Med 1996;26: 849–850.
Mathias CJ, May CN, Taylor GM. The renin angiotensin system and hypertension — basic and clinical aspects. In: Malcolm ADB, ed.Molecular Medicine, Vol. 1. Oxford: IRL Press, 1984; 177–208.
Mathias CJ, Frankel HL, Davies IBet al. Renin and aldosterone release during sympathetic stimulation in tetraplegia.Clin Sci 1981;60: 399–404.
Williams GH, Dluhy RG. Control of aldosterone secretion. In: Genest Jet al., eds.Hypertension, 2nd edn. New York: McGraw-Hill, 1983; 320.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
De Lorenzo, F., Hargreaves, J. & Kakkar, V.V. Pathogenesis and management of delayed orthostatic hypotention in patients with chronic fatigue syndrome. Clinical Autonomic Research 7, 185–190 (1997). https://doi.org/10.1007/BF02267980
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02267980